Security key
09073Q105
- Security type / class
- Equity / ADSs
- Total 13F shares
- 446,374
- Total 13F value
- $2,129,000
- Share change
- +22,635
- SEC-reported price per share
- $4.77
- Number of holders
- 10
- Value change
- +$105,507
- Number of buys
- 1
- Number of sells
- 3
- Shares outstanding
- 592,878
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2018
Institutions
10
Top holders
10
BVXV full security history
Ownership snapshot
Full 13F holder table
Scinai Immunotherapeutics Ltd. SEC filings
Scinai Immunotherapeutics Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of BVXV - Scinai Immunotherapeutics Ltd. - ADSs (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
IBEX INVESTORS LLC
Disclosed value leader
IBEX INVESTORS LLC
Comparable rows
0/11
Latest evidence
30 Sep 2018
13F
Highest disclosed value: $2,010,000
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
IBEX INVESTORS LLC has the largest disclosed position value at $2.01M.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens IBEX INVESTORS LLC's linked filing trail.
Disclosed position value
Top 5
IBEX INVESTORS LLC
$2.01M
BANK HAPOALIM BM
$141K
Vantage Investment Advisors, LLC
$140K
HighTower Advisors, LLC
$94K
Psagot Value Holdings Ltd.
$61K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| IBEX INVESTORS LLC |
13F
Company
|
—
denominator unverified
|
$2,010,000
359,000 shares
|
— | 30 Sep 2018 |
| BANK HAPOALIM BM |
13F
Company
|
—
denominator unverified
|
$141,000
25,176 shares
|
— | 30 Sep 2018 |
| Vantage Investment Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$140,000
25,045 shares
|
— | 30 Sep 2018 |
| HighTower Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$94,000
16,800 shares
|
— | 30 Sep 2018 |
| Psagot Value Holdings Ltd. |
13F
Company
|
—
denominator unverified
|
$61,000
10,877 shares
|
— | 30 Sep 2018 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$25,000
4,552 shares
|
— | 30 Sep 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
446,374
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
11
Q4 2018 holders
10
Holder diff
-1
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 value | Q4 2018 value | Value change | Value Chg % |
|---|